- Home
- GLMD vs FTFT Comparison
GLMD vs FTFT Comparison
Compare GLMD & FTFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GLMD
- FTFT
- Stock Information
- Founded
- GLMD 2000
- FTFT N/A
- Country
- GLMD Israel
- FTFT United States
- Employees
- GLMD N/A
- FTFT N/A
- Industry
- GLMD Biotechnology: Pharmaceutical Preparations
- FTFT Business Services
- Sector
- GLMD Health Care
- FTFT Consumer Discretionary
- Exchange
- GLMD Nasdaq
- FTFT Nasdaq
- Market Cap
- GLMD 4.5M
- FTFT 3.9M
- IPO Year
- GLMD 2014
- FTFT N/A
- Fundamental
- Price
- GLMD $1.46
- FTFT $0.13
- Analyst Decision
- GLMD
- FTFT
- Analyst Count
- GLMD 0
- FTFT 0
- Target Price
- GLMD N/A
- FTFT N/A
- AVG Volume (30 Days)
- GLMD 2.6M
- FTFT 644.0K
- Earning Date
- GLMD 05-29-2025
- FTFT 05-19-2025
- Dividend Yield
- GLMD N/A
- FTFT N/A
- EPS Growth
- GLMD N/A
- FTFT N/A
- EPS
- GLMD N/A
- FTFT N/A
- Revenue
- GLMD N/A
- FTFT $18,543,659.00
- Revenue This Year
- GLMD N/A
- FTFT N/A
- Revenue Next Year
- GLMD N/A
- FTFT N/A
- P/E Ratio
- GLMD N/A
- FTFT N/A
- Revenue Growth
- GLMD N/A
- FTFT N/A
- 52 Week Low
- GLMD $1.33
- FTFT $0.12
- 52 Week High
- GLMD $23.80
- FTFT $0.95
- Technical
- Relative Strength Index (RSI)
- GLMD 33.38
- FTFT 20.63
- Support Level
- GLMD $1.33
- FTFT $0.18
- Resistance Level
- GLMD $1.55
- FTFT $0.25
- Average True Range (ATR)
- GLMD 0.33
- FTFT 0.02
- MACD
- GLMD -0.04
- FTFT -0.00
- Stochastic Oscillator
- GLMD 5.90
- FTFT 8.66
About GLMD Galmed Pharmaceuticals Ltd.
Galmed Pharmaceuticals Ltd is a biopharmaceutical company. It focuses on the development and commercialization of once-daily, oral therapy for the treatment of liver diseases and cholesterol gallstones utilizing its synthetic fatty-acid/bile-acid conjugate (FABAC), called aramchol. Its product, aramchol, is a disease-modifying treatment for fatty liver disorders, including Non-Alcoholic Steato-hepatitis. Aramchol affects liver fat metabolism and has been shown in a Phase IIa clinical study to reduce liver fat content, as well as improve metabolic parameters associated with Nonalcoholic steatohepatitis.
About FTFT Future FinTech Group Inc.
Future FinTech Group Inc is engaged in the financial technology business. The company participates in supply chain financing services and trading in China, asset management business in Hong Kong, and cross-border money transfer services in the United Kingdom. It has also expanded into brokerage and investment banking business in Hong Kong and cryptocurrency mining farm in the U.S. The company's reportable segments include the Supply chain financing/trading segment which generates key revenue, and the Asset management service segment.